Related Experiment Videos

Prenatal diagnosis in Pelizaeus-Merzbacher disease using RFLP analysis

J Mäenpää1, E Lindahl, P Aula

  • 1Department of Medical Genetics, University of Turku, Finland.

Clinical Genetics
|February 1, 1990
PubMed

Insights

Pelizaeus-Merzbacher disease (PMD), a rare X-linked disorder, is linked to proteolipid protein (PLP) abnormalities. Genetic studies in a Finnish family enabled prenatal diagnosis, excluding PMD in one fetus and confirming carrier status in another.

Area of Science:

  • Neurogenetics
  • Molecular genetics

Background:

  • Pelizaeus-Merzbacher disease (PMD) is a rare X-linked recessive disorder characterized by severe psychomotor retardation and neurological deficits.
  • The disease results from inborn abnormalities in proteolipid protein (PLP), the primary protein component of myelin.

Observation:

  • A strong linkage between the proteolipid protein (PLP) gene and the PMD locus was hypothesized.
  • Restriction fragment length polymorphism (RFLP) studies were conducted using a PLP cDNA probe and the DXYS12 DNA fragment in a large Finnish family with multiple affected individuals.

Findings:

  • Genetic analysis of chorionic villus samples facilitated prenatal diagnosis.
  • The study successfully excluded PMD in a male fetus from a potential carrier mother.
  • Carrier status was identified in a female fetus from another at-risk pregnancy.

Implications:

  • These findings confirm the linkage between the PLP gene and PMD, providing a basis for genetic counseling.
  • Prenatal diagnosis using DNA analysis is crucial for families affected by PMD.
  • Understanding the genetic basis of PMD aids in diagnosing and managing this severe neurological disorder.

Related Concept Videos